G&S Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
G&S Capital's MRK Position: Q3 2026 in Review
G&S Capital increased its Merck (MRK) stake by 0.04% in Q3 2026, buying an estimated $415 and bringing the position to 7,329 shares worth $1.07M. The position accounts for 0.31% of the portfolio, ranked #88.
G&S Capital first reported a position in MRK in Q4 2017 and has held it in 13 quarters since. The position peaked at $4.05M in Q4 2019. 3,974 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- G&S Capital held 7,329 shares of Merck worth $1.07M as of Q3 2026.
- G&S Capital bought 3 Merck shares in Q3 2026, an estimated $415.
- Merck made up 0.31% of G&S Capital's portfolio in Q3 2026, its #88 holding.
- G&S Capital first reported a position in Merck in Q4 2017 and has held it in 13 quarters since.
- G&S Capital's Merck position peaked at $4.05M in Q4 2019.
- 3,974 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on G&S Capital's 13F filing for Q3 2026, filed 23 Oct 2026.